- Home
- NREF vs NTHI Comparison
NREF vs NTHI Comparison
Compare NREF & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NREF
- NTHI
- Stock Information
- Founded
- NREF 2019
- NTHI 2008
- Country
- NREF United States
- NTHI United States
- Employees
- NREF N/A
- NTHI N/A
- Industry
- NREF Real Estate Investment Trusts
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- NREF Real Estate
- NTHI Health Care
- Exchange
- NREF Nasdaq
- NTHI Nasdaq
- Market Cap
- NREF 233.4M
- NTHI 211.9M
- IPO Year
- NREF 2020
- NTHI N/A
- Fundamental
- Price
- NREF $13.83
- NTHI $11.27
- Analyst Decision
- NREF Hold
- NTHI
- Analyst Count
- NREF 3
- NTHI 0
- Target Price
- NREF $14.75
- NTHI N/A
- AVG Volume (30 Days)
- NREF 56.3K
- NTHI 49.2K
- Earning Date
- NREF 10-30-2025
- NTHI 12-18-2025
- Dividend Yield
- NREF 14.54%
- NTHI N/A
- EPS Growth
- NREF 142.14
- NTHI N/A
- EPS
- NREF 3.20
- NTHI N/A
- Revenue
- NREF $149,435,000.00
- NTHI $59,990.00
- Revenue This Year
- NREF $27.88
- NTHI N/A
- Revenue Next Year
- NREF $5.41
- NTHI N/A
- P/E Ratio
- NREF $4.29
- NTHI N/A
- Revenue Growth
- NREF 104.25
- NTHI N/A
- 52 Week Low
- NREF $12.14
- NTHI $3.20
- 52 Week High
- NREF $18.09
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- NREF 54.63
- NTHI N/A
- Support Level
- NREF $13.16
- NTHI N/A
- Resistance Level
- NREF $13.50
- NTHI N/A
- Average True Range (ATR)
- NREF 0.40
- NTHI 0.00
- MACD
- NREF 0.06
- NTHI 0.00
- Stochastic Oscillator
- NREF 95.02
- NTHI 0.00
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).